Class 4 Caution in use- Venlafaxine 150, 225 and 300mg XL tablets-Martindale brand

Additional to the batches included in the previous Class 4 Medicines Notification (reference EL(22)A/47), Martindale Pharma has made the MHRA aware that the GTIN in the 2D barcode and the printed variable data represents the branded version of the product (Venlalic® XL prolonged-release tablets).

MHRA drug alert date: 16th March 2023

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-macarthys-laboratories-t-slash-a-martindale-pharma-venlafaxine-xl-150mg-225mg-300mg-prolonged-release-tablets-el-23-a-slash-10?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=466f420a-5cf3-4fcc-8f9d-043cf1141af8&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For further information, medical enquiries and stock information, contact: Licensed@ethypharm.com.